Clean Science Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹264Cr
- +15.8% YoY
- +9.5% QoQ
- Net profit
- ₹74Cr
- +5.7% YoY
- +12.1% QoQ
- Margin
- 40%
- −2 pp YoY
- −1 pp QoQ
Guidance rank: #55 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years. Revenue potential is expected to be Rs. 2,500 to Rs. 3,000 crores within the next three years.
From Clean Science's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years.
- Existing products are expected to grow at an industry rate of 5-6% annually.
- New product launches, including performance chemicals and HALS, will drive significant growth and absorb overheads.
- HALS sales target: from Rs. 80 crores in FY '25 to Rs. 210 crores in FY '26 and ramping up fully by FY '27-’28 with total capacity over 10,000 tons.
- Performance chemicals (two new products) to commercialize in FY '26; revenue contribution expected mostly from FY '27 onward.
- MEHQ volumes anticipated to grow 4%-5% year-on-year.
2 more points from Clean Science's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Clean Science said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY ’25 CAPEX: Rs. 215 crores invested in subsidiary Clean Fino-Chem.
- FY ’26 CAPEX: Rs. 300 crores planned, primarily for two new performance chemical projects.
- One product commercialization expected by August FY ’26.
- Second product commercialization expected by February FY ’26.
- Further CAPEX plans for FY ’27 will be announced around six months after these products come online.
2 more points from Clean Science's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Clean Science said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Clean Science said on order book & pipeline — free account, 30 seconds.
Clean Science — Quarterly revenue & net profit
Clean Science Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 264 | 228 | +15.8% | 241 | +9.5% |
| Operating profit (EBITDA) | 105 | 95 | +10.5% | 98 | +7.1% |
| Operating margin | 40% | 42% | -2 pp | 41% | -1 pp |
| Profit before tax | 100 | 95 | +5.3% | 85 | +17.6% |
| Net profit (PAT) | 74 | 70 | +5.7% | 66 | +12.1% |
| EPS (₹) | 6.97 | 6.61 | +5.4% | 6.18 | +12.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹299 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Clean Science's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Atul (Q4 FY25)
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…
- Vidhi Specialty (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…
- Chemcon Speciality Chemicals (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Valiant Organics (Q4 FY25)
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Clean Science and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Clean Science Q4 FY25 results?
Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years. Revenue potential is expected to be Rs. 2,500 to Rs. 3,000 crores within the next three years.
What is Clean Science share price analysis?
Clean Science currently shows a neutral. The stock trades at a P/E of 37.7 with a market cap of ₹8,774 Cr. Investors should review the full earnings analysis for detailed insights.
Is Clean Science planning capital expenditure?
FY ’25 CAPEX: Rs. 215 crores invested in subsidiary Clean Fino-Chem.
Keep Clean Science on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
